Evidence map›Paper›PMID 32511883›Full record

ArticlePediatric pulmonology2020

Tobacco smoke exposure in pediatric cystic fibrosis: A qualitative study of clinician and caregiver perspectives on smoking cessation.

Gabriela R Oates, William T Harris, Hector H Gutierrez, Cathy Mims, Sarah B Rutland, Corilyn Ott, Soumya J Niranjan, Isabel C Scarinci, Susan C Walley

Open access · greenAbstract read
In one paragraph

Article in Pediatric pulmonology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Lung function and secondhand smoke exposure among children with cystic fibrosis: A Bayesian meta-analysis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2023
    Pooled it
  2. Tobacco smoke exposure is associated with diminished longitudinal benefit of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Speaking of pandemics...Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  8. Cessation of smoke exposure improves pediatric CF outcomes: Longitudinal analysis of CF Foundation Patient Registry data.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Gabriela R OatesPediatric Pulmonary and Sleep Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0003-4052-1524
William T HarrisPediatric Pulmonary and Sleep Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Hector H GutierrezPediatric Pulmonary and Sleep Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Cathy MimsChildren's of Alabama, Birmingham, Alabama.
Sarah B RutlandPediatric Pulmonary and Sleep Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Corilyn OttBirmingham Veterans Affairs Medical Center, Birmingham, Alabama.
Soumya J NiranjanDepartment of Health Services Administration, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama.
Isabel C ScarinciPreventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Susan C WalleyPediatric Hospital Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
University of Alabama at Birmingham · USBirmingham VA Medical Center · USChildren's of Alabama · USUniversity of Alabama at Birmingham Hospital · US

Funding

National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Brian R. Davis · 2007 to 2026
$23.0M
Translational Program in CFTR-Related Airway DiseasesR35HL135816 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROWE, STEVEN MARK · 2017 to 2022
$6.3M
UAB K12 in Patient Centered Outcomes ResearchK12HS023009 · AHRQ · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, KENNETH G · 2014 to 2018
$4.0M
Overcoming barriers to F508del CFTR correctionK08HL140190 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARRIS, WILLIAM THOMAS · 2018 to 2020
$505k
UAB Mentoring Program in COPD Patient Oriented ResearchK24HL140108 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DRANSFIELD, MARK T · 2018 to 2022
$439k
Oligotherapeutics to enhance CFTR correctionR03HL148467 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARRIS, WILLIAM THOMAS · 2019 to 2020
$149k
AHRQ HHS K12 HS023009AHRQ HHS K12HS023009NCATS NIH HHS UL1 TR001417NCATS NIH HHS UL1 TR003096NHLBI NIH HHS K08 HL140190NHLBI NIH HHS K24 HL140108NHLBI NIH HHS R03 HL148467NHLBI NIH HHS R35 HL135816NIDDK NIH HHS P30 DK072482NIH HHS K08HL140190, R03HL148467NIH HHS P30DK72482NIH HHS UL1TR001417
6 · The paper itself

Abstract

objectiveTobacco smoke exposure has negative impacts on the lung health of children with cystic fibrosis (CF), yet evidence-based strategies for smoking cessation have not been tested with or tailored to CF caregivers. This qualitative study identified barriers and facilitators of smoking cessation in this population and outlined potential interventional approaches.

methodsWe conducted semi-structured interviews with CF familial caregivers who were current or former smokers, and with members of the CF care team. We asked about experiences, practices, and prerequisites for a successful program. Interviews were recorded, transcribed verbatim, and coded by two investigators. Analysis used a thematic approach guided by the PRECEDE model, which identifies predisposing (intrapersonal), reinforcing (interpersonal), and enabling (structural) factors relevant to health behaviors and programs.

resultsSeventeen interviews were conducted-eight with familial caregivers and nine with CF team members. Whereas caregivers provided greater insight into internal difficulties and motivators to quit smoking, clinicians offered more extensive input on barriers and solutions related to the clinical environment. Based on study recommendations, a successful tobacco cessation program should include (a) family education about the harms of smoke exposure for children with CF; (b) screening for exposure, ideally with biochemical verification; (c) access to trained tobacco counselors; (d) affordable pharmacotherapy; and (e) outpatient follow-up of those undergoing tobacco treatment.

conclusionThis qualitative study revealed intrapersonal, interpersonal, and structural barriers to eliminating tobacco smoke exposure in children with CF, outlined opportunities to address these barriers, and made recommendations for a comprehensive tobacco cessation strategy.

Indexed as

Cystic FibrosisTobacco Smoke PollutionAdultCaregiversChildHumansInhalation ExposurePhysiciansSmoking CessationTobacco SmokingTobacco Smoke Pollutioncystic fibrosisqualitative methodssecond-hand smokesmoke exposuresmoking cessationtobacco

Identifiers

PMID32511883
PMCPMC7686064
OpenAlexW3030124130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.